• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重精神障碍患者的运动障碍与死亡率:库拉索锥体外系综合征研究 XIV。

Movement Disorders and Mortality in Severely Mentally Ill Patients: The Curacao Extrapyramidal Syndromes Study XIV.

机构信息

Research Department, Psychiatric Centre GGz Centraal, Amersfoort, The Netherlands.

School for Mental Health and NeuroScience (MHeNS), Maastricht University, Maastricht, The Netherlands.

出版信息

Schizophr Bull. 2022 Jun 21;48(4):766-773. doi: 10.1093/schbul/sbac037.

DOI:10.1093/schbul/sbac037
PMID:35486807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9212096/
Abstract

BACKGROUND AND HYPOTHESIS

There is a substantial gap in life expectancy between patients with severe mental illness (SMI) and the general population and it is important to understand which factors contribute to this difference. Research suggests an association between tardive dyskinesia (TD) and mortality; however, results are inconclusive. In addition, studies investigating associations between parkinsonism or akathisia and mortality are rare. We hypothesized that TD would be a risk factor for mortality in patients with SMI.

STUDY DESIGN

We studied a cohort of 157 patients diagnosed predominantly with schizophrenia on the former Netherlands Antilles. TD, parkinsonism, and akathisia were assessed with rating scales on eight occasions over a period of 18 years. Twenty-four years after baseline, survival status and if applicable date of death were determined. Associations between movement disorders and survival were analyzed using Cox regression. Sex, age, antipsychotics, antidepressants and benzodiazepines at each measurement occasion were tested as covariates.

STUDY RESULTS

Parkinsonism was a significant risk factor with an HR of 1.02 per point on the motor subscale of the Unified Parkinson's Disease Rating Scale (range 0-56). TD and akathisia were not significantly associated with mortality.

CONCLUSIONS

Parkinsonism may be an important risk factor for mortality in SMI patients. This finding calls for more follow-up and intervention studies to confirm this finding and to explore whether treatment or prevention of parkinsonism can reduce excess mortality.

摘要

背景与假设

严重精神疾病(SMI)患者的预期寿命与一般人群之间存在显著差距,了解哪些因素导致了这种差异非常重要。研究表明迟发性运动障碍(TD)与死亡率之间存在关联;然而,结果并不明确。此外,研究帕金森病或静坐不能与死亡率之间关联的研究很少。我们假设 TD 是 SMI 患者死亡的一个危险因素。

研究设计

我们研究了 157 名以前在荷属安的列斯群岛被诊断为主要患有精神分裂症的患者。使用评定量表在 18 年的时间里对 TD、帕金森病和静坐不能进行了八次评估。在基线后 24 年,确定了生存状况和可能的死亡日期。使用 Cox 回归分析运动障碍与生存之间的关联。在每次测量时,将性别、年龄、抗精神病药、抗抑郁药和苯二氮䓬类药物作为协变量进行测试。

研究结果

帕金森病的电机子量表每增加 1 分,风险比(HR)为 1.02(范围 0-56),是一个显著的危险因素。TD 和静坐不能与死亡率无显著相关性。

结论

帕金森病可能是 SMI 患者死亡的一个重要危险因素。这一发现需要更多的随访和干预研究来证实这一发现,并探讨是否可以通过治疗或预防帕金森病来降低超额死亡率。

相似文献

1
Movement Disorders and Mortality in Severely Mentally Ill Patients: The Curacao Extrapyramidal Syndromes Study XIV.严重精神障碍患者的运动障碍与死亡率:库拉索锥体外系综合征研究 XIV。
Schizophr Bull. 2022 Jun 21;48(4):766-773. doi: 10.1093/schbul/sbac037.
2
Early extrapyramidal side-effects as risk factors for later tardive dyskinesia: a prospective study.早期锥体外系副作用作为迟发性运动障碍的危险因素:一项前瞻性研究。
Aust N Z J Psychiatry. 2004 Jun;38(6):445-9. doi: 10.1080/j.1440-1614.2004.01382.x.
3
The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.迟发性运动障碍、帕金森症、静坐不能和迟发性肌张力障碍的相互关系:库拉索锥体外系综合征研究II
Schizophr Res. 1997 Aug 29;26(2-3):235-42. doi: 10.1016/s0920-9964(97)00058-3.
4
Effect of Antipsychotic Type and Dose Changes on Tardive Dyskinesia and Parkinsonism Severity in Patients With a Serious Mental Illness: The Curaçao Extrapyramidal Syndromes Study XII.抗精神病药物类型和剂量变化对重症精神疾病患者迟发性运动障碍和帕金森症严重程度的影响:库拉索锥体外系综合征研究十二
J Clin Psychiatry. 2017 Mar;78(3):e279-e285. doi: 10.4088/JCP.16m11049.
5
The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I.迟发性肌张力障碍、迟发性运动障碍、帕金森症和静坐不能的患病率:库拉索锥体外系综合征研究:I
Schizophr Res. 1996 May;19(2-3):195-203. doi: 10.1016/0920-9964(95)00096-8.
6
Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.氯氮平治疗精神分裂症患者的抗精神病药物所致迟发性运动障碍、帕金森症及慢性静坐不能。
J Clin Psychiatry. 1997 Jul;58(7):318-22. doi: 10.4088/jcp.v58n0706.
7
Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curaçao extrapyramidal syndromes study V.长期接受抗精神病药物治疗的非洲加勒比裔患者中迟发性运动障碍和迟发性肌张力障碍的发生率:库拉索锥体外系综合征研究V
J Clin Psychiatry. 2006 Dec;67(12):1920-7. doi: 10.4088/jcp.v67n1212.
8
Blink rate is associated with drug-induced parkinsonism in patients with severe mental illness, but does not meet requirements to serve as a clinical test: the Curacao extrapyramidal syndromes study XIII.眨眼频率与重症精神疾病患者的药物性帕金森综合征有关,但不符合作为临床检测指标的要求:库拉索锥体外系综合征研究 XIII。
J Negat Results Biomed. 2017 Aug 25;16(1):15. doi: 10.1186/s12952-017-0079-y.
9
Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.新型抗精神病药物、锥体外系副作用与迟发性运动障碍
Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S49-57. doi: 10.1097/00004850-199803003-00009.
10
Extrapyramidal syndromes in neuroleptic-treated patients: prevalence, risk factors, and association with tardive dyskinesia.接受抗精神病药物治疗患者的锥体外系综合征:患病率、危险因素及与迟发性运动障碍的关联
J Clin Psychopharmacol. 1999 Jun;19(3):203-8. doi: 10.1097/00004714-199906000-00002.

本文引用的文献

1
Cognition-Mortality Associations Are More Pronounced When Estimated Jointly in Longitudinal and Time-to-Event Models.当在纵向模型和事件发生时间模型中联合估计时,认知与死亡率的关联更为显著。
Front Psychol. 2021 Aug 6;12:708361. doi: 10.3389/fpsyg.2021.708361. eCollection 2021.
2
Exploring the Relationship Between Movement Disorders and Physical Activity in Patients With Schizophrenia: An Actigraphy Study.探讨精神分裂症患者运动障碍与身体活动之间的关系:一项基于活动记录仪的研究。
Schizophr Bull. 2021 Jul 8;47(4):906-914. doi: 10.1093/schbul/sbab028.
3
20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20).对全国范围内62250例精神分裂症患者队列(FIN20)进行的关于抗精神病药物治疗与身体发病率和死亡率关系的20年随访研究。
World Psychiatry. 2020 Feb;19(1):61-68. doi: 10.1002/wps.20699.
4
Mortality rate trends in patients diagnosed with schizophrenia or bipolar disorder: a nationwide study with 20 years of follow-up.精神分裂症或双相情感障碍患者的死亡率趋势:一项长达20年随访的全国性研究。
Int J Bipolar Disord. 2019 Mar 1;7(1):6. doi: 10.1186/s40345-018-0140-x.
5
Predictors of Mortality in Nondemented Patients With Parkinson Disease: Motor Symptoms Versus Nonmotor Symptoms.帕金森病非痴呆患者死亡率的预测因素:运动症状与非运动症状
J Geriatr Psychiatry Neurol. 2018 Jan;31(1):19-26. doi: 10.1177/0891988717743589. Epub 2017 Nov 30.
6
Swallowing Disorders in Schizophrenia.精神分裂症中的吞咽障碍。
Dysphagia. 2017 Aug;32(4):467-471. doi: 10.1007/s00455-017-9802-6. Epub 2017 Apr 26.
7
Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis.抗精神病药物与精神分裂症患者的长期死亡风险:系统评价和荟萃分析。
Psychol Med. 2017 Oct;47(13):2217-2228. doi: 10.1017/S0033291717000873. Epub 2017 Apr 11.
8
Lifestyle factors and the metabolic syndrome in Schizophrenia: a cross-sectional study.精神分裂症中的生活方式因素与代谢综合征:一项横断面研究。
Ann Gen Psychiatry. 2017 Feb 15;16:12. doi: 10.1186/s12991-017-0134-6. eCollection 2017.
9
Prediction of Neurocognitive Deficits by Parkinsonian Motor Impairment in Schizophrenia: A Study in Neuroleptic-Naïve Subjects, Unaffected First-Degree Relatives and Healthy Controls From an Indigenous Population.帕金森样运动障碍对精神分裂症神经认知缺陷的预测:一项针对未使用过抗精神病药物的受试者、未患病的一级亲属及来自本地人群的健康对照的研究
Schizophr Bull. 2016 Nov;42(6):1486-1495. doi: 10.1093/schbul/sbw023. Epub 2016 Mar 18.
10
Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study.精神分裂症患者的死亡率和抗精神病药、抗抑郁药和苯二氮䓬类药物的累积暴露量:一项观察性随访研究。
Am J Psychiatry. 2016 Jun 1;173(6):600-6. doi: 10.1176/appi.ajp.2015.15050618. Epub 2015 Dec 7.